PDB Short entry for 1QPL HEADER ISOMERASE 25-MAY-99 1QPL TITLE FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-707,587 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (FK506-BINDING PROTEIN); COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS IMMUNOPHILIN-DRUG COMPLEX, CIS-TRANS ISOMERASE, PEPTIDYL-PROLYL KEYWDS 2 ISOMERASE, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.W.BECKER,J.ROTONDA REVDAT 6 16-AUG-23 1QPL 1 REMARK REVDAT 5 24-JAN-18 1QPL 1 JRNL REVDAT 4 04-OCT-17 1QPL 1 REMARK REVDAT 3 24-FEB-09 1QPL 1 VERSN REVDAT 2 28-JUN-00 1QPL 1 SOURCE REVDAT 1 16-AUG-99 1QPL 0 JRNL AUTH J.W.BECKER,J.ROTONDA,J.G.CRYAN,M.MARTIN,W.H.PARSONS, JRNL AUTH 2 P.J.SINCLAIR,G.WIEDERRECHT,F.WONG JRNL TITL 32-INDOLYL ETHER DERIVATIVES OF ASCOMYCIN: THREE-DIMENSIONAL JRNL TITL 2 STRUCTURES OF COMPLEXES WITH FK506-BINDING PROTEIN. JRNL REF J.MED.CHEM. V. 42 2798 1999 JRNL REFN ISSN 0022-2623 JRNL PMID 10425089 JRNL DOI 10.1021/JM9806042 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.B.PETERSON,J.G.CRYAN,R.ROSA,M.M.MARTIN,M.B.WILUSZ, REMARK 1 AUTH 2 P.J.SINCLAIR,F.WONG,J.N.PARSONS,S.J.O'KEEFE,W.H.PARSONS, REMARK 1 AUTH 3 M.WYVRATT,N.H.SIGAL,A.R.WILLIAMSON,G.J.WIEDERRECHT REMARK 1 TITL A TACROLIMUS-RELATED IMMUNOSUPPRESSANT WITH BIOCHEMICAL REMARK 1 TITL 2 PROPERTIES DISTINCT FROM THOSE OF TACROLIMUS. REMARK 1 REF TRANSPLANTATION V. 65 10 1998 REMARK 1 REFN ISSN 0041-1337 REMARK 1 DOI 10.1097/00007890-199801150-00004 REMARK 1 REFERENCE 2 REMARK 1 AUTH F.J.DUMONT,S.KOPRAK,M.J.STARUCH,A.TALENTO,G.KOO,C.DASILVA, REMARK 1 AUTH 2 P.J.SINCLAIR,F.WONG,J.WOODS,J.BARKER,J.PIVNICHNY,I.SINGER, REMARK 1 AUTH 3 N.H.SIGAL,A.R.WILLIAMSON,W.H.PARSONS,M.WYVRATT REMARK 1 TITL A TACROLIMUS-RELATED IMMUNOSUPPRESSANT WITH REDUCED REMARK 1 TITL 2 TOXICITY. REMARK 1 REF TRANSPLANTATION V. 65 18 1998 REMARK 1 REFN ISSN 0041-1337 REMARK 1 DOI 10.1097/00007890-199801150-00005 REMARK 1 REFERENCE 3 REMARK 1 AUTH P.J.SINCLAIR,F.WONG,M.J.STARUCH,G.WIEDERRECHT,W.H.PARSONS, REMARK 1 AUTH 2 F.DUMONT,M.WYVRATT REMARK 1 TITL PREPARATION AND IN VITRO ACTIVITIES OF NAPHTHYL AND INDOLYL REMARK 1 TITL 2 ETHER DERIVATIVES OF THE FK-506 RELATED IMMUNOSUPPRESSIVE REMARK 1 TITL 3 MACROLIDE ASCOMYCIN. REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 6 2193 1996 REMARK 1 REFN ISSN 0960-894X REMARK 1 DOI 10.1016/0960-894X(96)00398-8 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 8527 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : A POSTERIORI REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.342 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.600 REMARK 3 FREE R VALUE TEST SET COUNT : 903 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 675 REMARK 3 BIN R VALUE (WORKING SET) : 0.3370 REMARK 3 BIN FREE R VALUE : 0.3420 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 46 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1664 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 134 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 68.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM SIGMAA (A) : 0.51 REMARK 3 LOW RESOLUTION CUTOFF (A) : 20.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.51 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.49 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.190 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QPL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUN-99. REMARK 100 THE DEPOSITION ID IS D_1000009118. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-91 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 6.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HARVARD DATA COLLECTION SYSTEM REMARK 200 FOR X-RAY AREA DETECTORS V. 2.0- REMARK 200 03 REMARK 200 DATA SCALING SOFTWARE : X-GEN, FBSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12979 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 42.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.1 REMARK 200 DATA REDUNDANCY : 6.410 REMARK 200 R MERGE (I) : 0.05850 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 29.2800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 57.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MERLOT REMARK 200 STARTING MODEL: PROTEIN PORTION OF PDB ENTRY 1FKD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, POTASSIUM PHOSPHATE, REMARK 280 PH 6.1 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 59.87000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.87000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 28.60500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 59.87000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.87000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.60500 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 59.87000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 59.87000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 28.60500 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 59.87000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 59.87000 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 28.60500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 18 96.80 -61.15 REMARK 500 ASP A 32 35.34 -79.10 REMARK 500 LYS A 34 118.49 -34.10 REMARK 500 SER A 38 114.27 -162.59 REMARK 500 ASN A 43 12.14 50.20 REMARK 500 ALA A 81 -116.58 -113.92 REMARK 500 TYR A 82 61.76 -116.60 REMARK 500 PRO A 88 120.52 -36.97 REMARK 500 ARG C 213 -55.65 -130.04 REMARK 500 ARG C 218 107.66 -54.87 REMARK 500 ASP C 232 30.00 -92.82 REMARK 500 GLN C 253 81.37 -56.75 REMARK 500 ALA C 281 -97.13 -115.00 REMARK 500 TYR C 282 -66.23 -123.51 REMARK 500 ALA C 284 -81.43 -54.82 REMARK 500 HIS C 287 107.38 -161.06 REMARK 500 PRO C 288 113.94 -39.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 587 A 108 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 587 C 308 DBREF 1QPL A 1 107 UNP P62942 FKB1A_HUMAN 1 107 DBREF 1QPL C 201 307 UNP P62942 FKB1A_HUMAN 1 107 SEQRES 1 A 107 GLY VAL GLN VAL GLU THR ILE SER PRO GLY ASP GLY ARG SEQRES 2 A 107 THR PHE PRO LYS ARG GLY GLN THR CYS VAL VAL HIS TYR SEQRES 3 A 107 THR GLY MET LEU GLU ASP GLY LYS LYS PHE ASP SER SER SEQRES 4 A 107 ARG ASP ARG ASN LYS PRO PHE LYS PHE MET LEU GLY LYS SEQRES 5 A 107 GLN GLU VAL ILE ARG GLY TRP GLU GLU GLY VAL ALA GLN SEQRES 6 A 107 MET SER VAL GLY GLN ARG ALA LYS LEU THR ILE SER PRO SEQRES 7 A 107 ASP TYR ALA TYR GLY ALA THR GLY HIS PRO GLY ILE ILE SEQRES 8 A 107 PRO PRO HIS ALA THR LEU VAL PHE ASP VAL GLU LEU LEU SEQRES 9 A 107 LYS LEU GLU SEQRES 1 C 107 GLY VAL GLN VAL GLU THR ILE SER PRO GLY ASP GLY ARG SEQRES 2 C 107 THR PHE PRO LYS ARG GLY GLN THR CYS VAL VAL HIS TYR SEQRES 3 C 107 THR GLY MET LEU GLU ASP GLY LYS LYS PHE ASP SER SER SEQRES 4 C 107 ARG ASP ARG ASN LYS PRO PHE LYS PHE MET LEU GLY LYS SEQRES 5 C 107 GLN GLU VAL ILE ARG GLY TRP GLU GLU GLY VAL ALA GLN SEQRES 6 C 107 MET SER VAL GLY GLN ARG ALA LYS LEU THR ILE SER PRO SEQRES 7 C 107 ASP TYR ALA TYR GLY ALA THR GLY HIS PRO GLY ILE ILE SEQRES 8 C 107 PRO PRO HIS ALA THR LEU VAL PHE ASP VAL GLU LEU LEU SEQRES 9 C 107 LYS LEU GLU HET 587 A 108 67 HET 587 C 308 67 HETNAM 587 C32-O-(1-METHYL-INDOL-5-YL) 18-HYDROXY-ASCOMYCIN HETSYN 587 L-709,587 FORMUL 3 587 2(C52 H76 N2 O13) FORMUL 5 HOH *14(H2 O) HELIX 1 1 ILE A 56 GLN A 65 1 10 HELIX 2 2 PRO A 78 ALA A 81 5 4 HELIX 3 3 SER C 239 ASN C 243 1 5 HELIX 4 4 ILE C 256 GLN C 265 1 10 HELIX 5 5 PRO C 278 ALA C 281 5 4 SHEET 1 A 5 VAL A 2 SER A 8 0 SHEET 2 A 5 ARG A 71 ILE A 76 -1 O ARG A 71 N ILE A 7 SHEET 3 A 5 LEU A 97 LEU A 106 -1 N LEU A 97 O ILE A 76 SHEET 4 A 5 THR A 21 LEU A 30 -1 O MET A 29 N VAL A 98 SHEET 5 A 5 LYS A 35 SER A 38 -1 N PHE A 36 O GLY A 28 SHEET 1 A1 5 VAL A 2 SER A 8 0 SHEET 2 A1 5 ARG A 71 ILE A 76 -1 O ARG A 71 N ILE A 7 SHEET 3 A1 5 LEU A 97 LEU A 106 -1 N LEU A 97 O ILE A 76 SHEET 4 A1 5 THR A 21 LEU A 30 -1 O MET A 29 N VAL A 98 SHEET 5 A1 5 PHE A 46 MET A 49 -1 O PHE A 46 N VAL A 24 SHEET 1 B 5 VAL C 202 SER C 208 0 SHEET 2 B 5 ARG C 271 ILE C 276 -1 O ARG C 271 N ILE C 207 SHEET 3 B 5 LEU C 297 LEU C 306 -1 O LEU C 297 N ILE C 276 SHEET 4 B 5 THR C 221 LEU C 230 -1 O MET C 229 N VAL C 298 SHEET 5 B 5 LYS C 235 SER C 238 -1 N PHE C 236 O GLY C 228 SHEET 1 B1 5 VAL C 202 SER C 208 0 SHEET 2 B1 5 ARG C 271 ILE C 276 -1 O ARG C 271 N ILE C 207 SHEET 3 B1 5 LEU C 297 LEU C 306 -1 O LEU C 297 N ILE C 276 SHEET 4 B1 5 THR C 221 LEU C 230 -1 O MET C 229 N VAL C 298 SHEET 5 B1 5 PHE C 246 MET C 249 -1 O PHE C 246 N VAL C 224 SITE 1 AC1 18 TYR A 26 PHE A 36 ASP A 37 ARG A 42 SITE 2 AC1 18 PHE A 46 GLU A 54 VAL A 55 ILE A 56 SITE 3 AC1 18 TRP A 59 ALA A 81 TYR A 82 ILE A 91 SITE 4 AC1 18 PHE A 99 ILE C 207 SER C 208 GLN C 253 SITE 5 AC1 18 HIS C 287 587 C 308 SITE 1 AC2 14 GLN A 53 GLU A 54 VAL A 55 587 A 108 SITE 2 AC2 14 THR C 206 TYR C 226 ASP C 237 PHE C 246 SITE 3 AC2 14 GLU C 254 VAL C 255 ILE C 256 TRP C 259 SITE 4 AC2 14 ALA C 281 TYR C 282 CRYST1 119.740 119.740 57.210 90.00 90.00 90.00 I 4 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008351 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008351 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017479 0.00000